Brief: Transcode Announces The Acquisition Of Polynoma And A $25 Mln Financing By Subsidiary Of CK Life Sciences

Transcode Therapeutics

08/10/2025 13:24

Oct 8 (Reuters) - Transcode Therapeutics Inc RNAZ.O:

TRANSCODE THERAPEUTICS (RNAZ) ANNOUNCES THE ACQUISITION OF POLYNOMA AND A $25 MILLION STRATEGIC FINANCING BY A SUBSIDIARY OF CK LIFE SCIENCES TO FORM A FIRST-IN-CLASS UNIQUE IMMUNO-ONCOLOGY AND METASTATIC PREVENTION ONCOLOGY COMPANY

TRANSCODE THERAPEUTICS INC - CONCURRENT EQUITY INVESTMENT OF $25 MILLION FROM CK LIFE SCIENCES INTO TRANSCODE

TRANSCODE THERAPEUTICS INC: PHILIPPE CALAIS APPOINTED AS TRANSCODE'S CHIEF EXECUTIVE OFFICER AND REMAINS CHAIRMAN

TRANSCODE THERAPEUTICS INC: TOM FITZGERALD STEPS DOWN AS INTERIM CHIEF EXECUTIVE OFFICER BUT REMAINS CHIEF FINANCIAL OFFICER

Source text: ID:nPnbw5smsa

Further company coverage: RNAZ.O

 ((Reuters.Briefs@thomsonreuters.com;))